NeuroMetrix Inc (NURO)

0.90
NASDAQ : Health Care
Prev Close 0.95
Day Low/High 0.88 / 0.95
52 Wk Low/High 0.88 / 2.96
Avg Volume 76.80K
Exchange NASDAQ
Shares Outstanding 5.32M
Market Cap 5.05M
EPS -7.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NeuroMetrix Announces That Quell Will Be Featured On The Henry Ford Innovation Nation

NeuroMetrix Announces That Quell Will Be Featured On The Henry Ford Innovation Nation

NeuroMetrix, Inc. (Nasdaq: NURO,NUROW) announced today that its Quell ® Wearable Pain Relief Technology™ will be featured on the November 26 th episode of The Henry Ford Innovation Nation which airs on the...

NeuroMetrix' Quell Device Makes Second Appearance At American Society Of Regional Anesthesia's Annual Pain Medicine Meeting

NeuroMetrix' Quell Device Makes Second Appearance At American Society Of Regional Anesthesia's Annual Pain Medicine Meeting

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Quell ® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American Society for Regional Anesthesia's...

NeuroMetrix Reports DPNCheck Introduction At The Annual Meeting Of The China Diabetes Society

NeuroMetrix Reports DPNCheck Introduction At The Annual Meeting Of The China Diabetes Society

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today reported that DPNCheck ®, a diagnostic test for peripheral neuropathy, will be introduced at the 20 th Scientific Meeting of the Chinese Diabetes Society during November...

NeuroMetrix Chief Commercial Officer Frank McGillin To Present Quell Wearable Pain Relief Technology At 16th Annual Diabetes Technology Meeting

NeuroMetrix Chief Commercial Officer Frank McGillin To Present Quell Wearable Pain Relief Technology At 16th Annual Diabetes Technology Meeting

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Senior Vice President and Chief Commercial Officer Frank McGillin will present on Quell ® Wearable Pain Relief Technology™ during the 16th Annual...

NeuroMetrix Announces Promotion Of Frank McGillin To Chief Commercial Officer

NeuroMetrix Announces Promotion Of Frank McGillin To Chief Commercial Officer

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that it has promoted Frank McGillin to Senior Vice President and Chief Commercial Officer.

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the U.

NeuroMetrix To Present At 2016 Sidoti Emerging Growth Convention

NeuroMetrix To Present At 2016 Sidoti Emerging Growth Convention

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) announced today that Shai N.

NeuroMetrix Reports Q3 2016 Financial Results

NeuroMetrix Reports Q3 2016 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business highlights for the quarter and nine month periods ended September 30, 2016.

NeuroMetrix Announces Participation At The 2016 Partners Connected Health Symposium

NeuroMetrix Announces Participation At The 2016 Partners Connected Health Symposium

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it will be an active participant at the Connected Health Symposium on October 20-21 in Boston sponsored by Partners Healthcare.

NeuroMetrix, Inc. Announces Date For 2016 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. Announces Date For 2016 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that it plans to issue its 2016 third quarter financial results before the opening of the market on Thursday, October 20, 2016.

NeuroMetrix Announces Participation In Discover Blue: New York City Bluetooth Event

NeuroMetrix Announces Participation In Discover Blue: New York City Bluetooth Event

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it has been selected to showcase Quell ® Wearable Pain Relief Technology™ at the Discover Blue: New York City event hosted by the Bluetooth Special...

NeuroMetrix To Present At 5th Annual Diabetic Peripheral Neuropathy Fellowship For Chinese Physicians At The University Of Sheffield

NeuroMetrix To Present At 5th Annual Diabetic Peripheral Neuropathy Fellowship For Chinese Physicians At The University Of Sheffield

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today announced that Dr.

NeuroMetrix To Sponsor Study Assessing The Impact Of Quell Technology On Chronic Low Back Pain

NeuroMetrix To Sponsor Study Assessing The Impact Of Quell Technology On Chronic Low Back Pain

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today announced a clinical study of Quell ® Wearable Pain Relief Technology™ in patients with chronic low back pain at the Brigham and Women's Hospital Pain Management...

NeuroMetrix Announces Frank McGillin Will Speak At The 2016 Wearable Technology Show

NeuroMetrix Announces Frank McGillin Will Speak At The 2016 Wearable Technology Show

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced that Frank McGillin, Senior Vice President and General Manger, Consumer, will participate in a panel discussion on the THE DIGITAL HEALTHCARE REVOLUTION at the Wearable...

NeuroMetrix Announces Quell Fibromyalgia Pilot With Synovation Medical Group

NeuroMetrix Announces Quell Fibromyalgia Pilot With Synovation Medical Group

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Synovation Medical Group will conduct an evaluation of Quell ® Wearable Pain Relief Technology™ in fibromyalgia patients.

NeuroMetrix Reports Progress On Quell Availability Within The Veterans Health Administration

NeuroMetrix Reports Progress On Quell Availability Within The Veterans Health Administration

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today on multiple efforts to increase the availability of Quell ® Wearable Pain Relief Technology™ to veterans who suffer from chronic pain through the...

NeuroMetrix Wins Electronics Retailer Association Award For Quell TV Advertising

NeuroMetrix Wins Electronics Retailer Association Award For Quell TV Advertising

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that the Company's Quell ® Wearable Pain Relief Technology™ has won the Electronics Retailer Association Moxie Award for the Best Health Show 2016.

NeuroMetrix Reports Final Approval To Market DPNCheck In China

NeuroMetrix Reports Final Approval To Market DPNCheck In China

NeuroMetrix, Inc. (Nasdaq: NURO) today reported final regulatory approval in China for DPNCheck ®, a diagnostic test for peripheral neuropathy.

NeuroMetrix Announces Quell Dispensing Partnership With Comprehensive Pain Specialists

NeuroMetrix Announces Quell Dispensing Partnership With Comprehensive Pain Specialists

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Comprehensive Pain Specialists will offer Quell ® Wearable Pain Relief Technology™ in selected clinic locations.

NeuroMetrix Announces Participation At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City September 11-13th, 2016

NeuroMetrix Announces Participation At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City September 11-13th, 2016

NeuroMetrix, Inc. (NASDAQ:NURO) today announced it will be featured as a presenting company at the 18 th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.

NeuroMetrix Announces Issuance Of Patent For DPNCheck Core Technology In China

NeuroMetrix Announces Issuance Of Patent For DPNCheck Core Technology In China

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the State Intellectual Property Office of the People's Republic of China has issued Chinese Patent No.

NeuroMetrix Launches New Website To Support Growth Of Quell Wearable Pain Relief Technology

NeuroMetrix Launches New Website To Support Growth Of Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (NASDAQ:NURO) today announced the launch of a new website to promote Quell ®, the company's rapidly growing pain relief brand.

NeuroMetrix Announces That Quell Will Be Featured In The Target Open House

NeuroMetrix Announces That Quell Will Be Featured In The Target Open House

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell ® will be featured in the Target Open House in San Francisco.

NeuroMetrix Celebrates 10,000 Quell Facebook Fans With Pain Awareness Month Contest

NeuroMetrix Celebrates 10,000 Quell Facebook Fans With Pain Awareness Month Contest

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that to celebrate having reached 10,000 fans for Quell ® Pain Relief on Facebook, it will give away a contest prize each day during September which is Pain Awareness...

NeuroMetrix Commentary On Strategic And Business Partnerships For Quell Wearable Pain Relief Technology

NeuroMetrix Commentary On Strategic And Business Partnerships For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (NASDAQ:NURO) today provided commentary on its Quell ® partnership strategy.

NeuroMetrix To Present Quell Wearable Pain Technology At National Association Of Chain Drug Stores Total Store Expo

NeuroMetrix To Present Quell Wearable Pain Technology At National Association Of Chain Drug Stores Total Store Expo

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that the company, in partnership with Advantage Healthcare, will explore Quell ® retail expansion plans with executives from key national and regional drug...

NeuroMetrix Reports That The Quell Health Cloud Has Collected Over 1 Million Hours Of Quell Therapy And Health Data

NeuroMetrix Reports That The Quell Health Cloud Has Collected Over 1 Million Hours Of Quell Therapy And Health Data

NeuroMetrix, Inc. (NASDAQ:NURO) announced a major milestone with over 1 million hours of Quell ® therapy and health data uploaded to the Quell Health Cloud as of August 1, 2016.

NeuroMetrix Reports Recent Media Coverage For Quell

NeuroMetrix Reports Recent Media Coverage For Quell

NeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media attention focusing on the company's innovative Quell ® Wearable Pain Relief Technology ™.